ANIX · Anixa Biosciences Inc · Documents
Market Cap
$101.22M
Shares
34.02M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-09-09 | 2026-07-31 | |
| 10-Q | 2026-06-10 | 2026-04-30 | |
| 8-K | 2026-03-11 | 2026-03-10 | |
| 10-Q | 2026-03-09 | 2026-01-31 | |
| 8-K | 2026-02-09 | — | |
| DEF 14A | 2026-01-28 | — | |
| 10-K | 2026-01-12 | 2025-10-31 | |
| 8-K | 2025-12-12 | 2025-12-11 | |
| 10-Q | 2025-09-10 | 2025-07-31 | |
| 10-Q | 2025-05-28 | 2025-04-30 | |
| 8-K | 2025-03-21 | 2025-03-20 | |
| 10-Q | 2025-03-11 | 2025-01-31 | |
| DEF 14A | 2025-02-06 | 2024-10-31 | |
| 10-K | 2025-01-10 | 2024-10-31 | |
| 8-K | 2024-11-08 | — | |
| 10-Q | 2024-09-06 | 2024-07-31 | |
| 10-Q | 2024-06-04 | 2024-04-30 | |
| 8-K | 2024-05-08 | 2024-05-03 | |
| 8-K | 2024-03-22 | 2024-03-21 | |
| 10-Q | 2024-03-12 | 2024-01-31 | |
| DEF 14A | 2024-02-08 | — | |
| 10-K | 2024-01-16 | 2023-10-31 | |
| 8-K | 2023-12-07 | 2023-12-06 | |
| 10-Q | 2023-09-06 | 2023-07-31 | |
| 10-Q | 2023-06-14 | 2023-04-30 | |
| 8-K | 2023-04-17 | — | |
| 10-Q | 2023-03-17 | 2023-01-31 | |
| 8-K | 2023-03-10 | 2023-03-09 | |
| DEF 14A | 2023-01-27 | — | |
| 10-K | 2023-01-04 | 2022-10-31 | |
| 8-K | 2022-12-08 | — | |
| 8-K | 2022-09-29 | 2022-09-28 | |
| 10-Q | 2022-09-09 | 2022-07-31 | |
| 8-K | 2022-08-17 | 2022-08-15 | |
| 10-Q | 2022-06-10 | 2022-04-30 | |
| 8-K | 2022-04-15 | 2022-04-14 | |
| 8-K | 2022-03-11 | 2022-03-10 | |
| 10-Q | 2022-03-11 | 2022-01-31 | |
| DEF 14A | 2022-01-28 | — | |
| 10-K | 2022-01-04 | 2021-10-31 | |
| 8-K | 2021-12-09 | 2021-12-07 | |
| 8-K | 2021-10-28 | 2021-10-26 | |
| 8-K | 2021-10-04 | 2021-10-01 | |
| 10-Q | 2021-09-01 | 2021-07-31 | |
| 8-K | 2021-06-16 | — | |
| 10-Q | 2021-06-10 | 2021-04-30 | |
| 8-K | 2021-05-27 | 2021-05-21 | |
| DEF 14A | 2021-04-09 | — | |
| 8-K | 2021-04-02 | 2021-03-29 | |
| 8-K | 2021-03-24 | 2021-03-22 |
Showing 1–50 of 64 filings
Key facts
CIK
715446
CUSIP
03528H109
13F (30d)
36 filings
36 filers
Visit website
Investor relations